Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: Sterile Allogeneic Spongioflex® Allograft as Partial Meniscal Replacement After Incomplete Meniscal Loss [NA]

View source ↗

Summary

Clinical trial evaluating sterile allogeneic Spongioflex Allograft as partial meniscal replacement for meniscal lesions; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spongioflex® Allograft (spongioflex allograft)

Snippet

Sponsor: Sven Behrendt | Conditions: Meniscus Lesion | NA | Status: RECRUITING